Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes

Michał Kukla1,2, Tomasz Menżyk3, Marcin Dembiński2,4

  • 1Department of Internal Medicine and Geriatrics, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.

Scientific Reports
|November 3, 2021
PubMed

Insights

COVID-19 patients showed lower levels of chemerin and omentin, adipokines involved in inflammation. These adipokine deficiencies did not correlate with disease severity, but elevated GGT activity predicted worse outcomes in COVID-19.

Area of Science:

  • Biochemistry
  • Immunology
  • Endocrinology

Background:

  • Coronavirus disease 2019 (COVID-19) is linked to systemic inflammation.
  • Adipokines, signaling proteins from adipose tissue, may influence COVID-19 pathogenesis and disease progression.
  • Chemerin, omentin, and vaspin are adipokines with diverse biological activities.

Purpose of the Study:

  • To evaluate serum concentrations of chemerin, omentin, and vaspin in COVID-19 patients.
  • To investigate the relationship between these adipokines and COVID-19 severity.
  • To explore associations with metabolic abnormalities and liver dysfunction in COVID-19 patients.

Main Methods:

  • Serum samples were collected from 70 COVID-19 patients upon hospital admission and 20 healthy controls.
  • Concentrations of chemerin, omentin, and vaspin were measured.
  • COVID-19 severity was assessed based on pneumonia, dyspnea, and ICU admission. Liver function tests were performed.

Main Results:

  • COVID-19 patients exhibited significantly lower serum concentrations of chemerin and omentin compared to healthy controls.
  • No correlation was found between adipokine levels and COVID-19 severity markers (pneumonia, dyspnea, ICU stay).
  • Elevated gamma-glutamyl transferase (GGT) activity was associated with ICU admission, pneumonia, and higher levels of inflammatory markers (CRP, ferritin, IL-6).

Conclusions:

  • The depletion of chemerin and omentin in COVID-19 patients suggests a potential role in disease pathogenesis.
  • Adipokine levels did not correlate with the frequency of COVID-19 symptoms or overall disease severity.
  • Elevated GGT activity emerged as a potential predictor of severe COVID-19, including pneumonia and ICU hospitalization.